Skip to content

Nottinghamshire Environmental Village Project

Nottinghamshire nidotherapy project

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN12178260
Enrollment
300
Registered
2024-06-11
Start date
2024-08-20
Completion date
Unknown
Last updated
2026-01-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Improving social function and life satisfaction in whole communities Mental and Behavioural Disorders

Interventions

A cluster-randomised step-wedged trial is planned in six village communities in Nottinghamshire, England covering an adult population of 622. The population in all six villages will be offered a full

Sponsors

Nottingham Trent University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 100 Years

Inclusion criteria

Inclusion criteria: 1. Adult with full mental capacity 2. Able to give informed consent

Exclusion criteria

Exclusion criteria: 1. Serious life-threatening physical illness 2. Lack of mental capacity

Design outcomes

Primary

MeasureTime frame
Current primary outcome measure as of 24/06/2024: Impaired functioning measured using the Short Social Functioning Questionnaire (SSFQ) at baseline and 3, 6, 9 and 12 months Previous primary outcome measure: Impaired functioning measured using the Work and Social Adjustment Scale (WSAS) at baseline and 3, 6, 9 and 12 months

Secondary

MeasureTime frame
Current secondary outcome measures as of 24/06/2024: The following secondary outcome measures are assessed at baseline and 12 months, 1. Anxiety and depression measured using the Hospital Anxiety and Depression Scale (HADS) 2. Personality strengths measured using the Abbreviated Personality Strengths Scale (APSS) 3. Quality of life measured using the Recovering Quality of Life (ReQoL) scale 4. Personality status measured using the Structured Assessment of Personality Abbreviated Scale (SAPAS) 5. Social cohesion measured using the PROMIS-SF (a four-item scale) 6. Personality disorder measured using the Personality Assessment Schedule for ICD-11 (PAS-ICD-11) 7. Personality traits measured using the Personality Assessment Questionnaire for ICD-11 (PAQ-11) The following scales will also be administered at 3, 6 and 9 months: 1. Anxiety and depression measured using the Hospital Anxiety and Depression Scale (HADS) 2. Impaired functioning measured using the Short Social Functioning Questionnaire An Environmental Checklist will be given before all other assessments at baseline, 3,6, 9 and 12 months A community satisfaction scale will be given at 12 months Previous secondary outcome measure: The following secondary outcome measures are assessed at baseline and 3, 6, 9 and 12 months, except satisfaction which is assessed at 12 months: 1. Anxiety and depression measured using the Hospital Anxiety and Depression Scale (HADS) scoring 2. Changes in personality strengths measured using the Abbreviated Personality Strengths Scale (APSS) 3. Changes in quality of life measured using the Recovering Quality of Life (ReQoL) scale 4. Change in costs of nidotherapy measured using a record of total individual and community costs developed by Professor Barbara Brett (King’s Health Economics) 5. Satisfaction with care measured using the Client Satisfaction Scale (CSQ-8) 6. Personality disorder measured using the Structured Assessment of Personality Abbreviated Scale (SAPAS)

Countries

England, United Kingdom

Contacts

Public ContactPeter Tyrer
p.tyrer@imperial.ac.uk+44 (0)7714765885

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026